Advice for developers in steering gene therapies from concept to trials to hopeful approval in what is an uniquely complex path.
Angi Robinson
Advertisement
VP, Rare Diseases & PediatricsPremier Research
Articles by Angi Robinson
Advertisement
Latest Updated Articles
Gene Therapy: Managing the Clinical Trial MinefieldsPublished: August 13th 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
2
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
3
Direct-to-patient: pharma’s next power move
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
